NCT00488566View on ClinicalTrials.gov

GSK Drug Single Dose Escalation And Their Effect On Resting Motor Threshold In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions

Bipolar Disorder

Interventions

DRUG

GSK drug

GSK drug

OTHER

Placebo

Placebo

OTHER

Lamictal

Positive control

Trial Locations (2)

HA13UJ

GSK Investigational Site, Harrow

SE1 1YR

GSK Investigational Site, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Biogen

INDUSTRY